Bank Of Montreal Palatin Technologies Inc Transaction History

Bank Of Montreal

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$0.37 - $0.54 $2,978 - $4,347	-8,050 Reduced 44.6%	10,000 $4,000
Q4 2021 Feb 11, 2022	BUY	$0.34 - $0.86 $2,737 - $6,923	8,050 Added 80.5%	18,050 $10,000
Q2 2021 Aug 12, 2021	BUY	$0.48 - $0.72 $4,800 - $7,200	10,000 New	10,000 $7,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $8.83M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.